4th Update on Fabry Nephropathy: Biomarkers, Progression and Treatment Opportunities. June 1-2, 2015, Manchester, UK: Abstracts

Publisher： Karger

E-ISSN： 2235-3186|130|2|77-91

ISSN： 1660-8151

Source： Nephron, Vol.130, Iss.2, 2015-05, pp. : 77-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

5th Update on Fabry Nephropathy: Biomarkers, Progression and Treatment Opportunities. April 25-27, 2017, Mexico City, Mexico: Abstracts

By  

Nephron, Vol. 136, Iss. 3, 2017-04 ,pp. : 163-182

Karger

Access to resources Recommend Favorite

Antioxidative Treatment Retards Progression of Idiopathic Membranous Nephropathy

By  

Nephron, Vol. 86, Iss. 2, 2000-09 ,pp. : 208-209

Karger

Access to resources Recommend Favorite

UK Renal Registry 19th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2015

By  

Nephron, Vol. 137, Iss. 1, 2017-09 ,pp. : 103-116

Karger

Access to resources Recommend Favorite

Progression of Diabetic Nephropathy

By  

Kidney and Blood Pressure Research, Vol. 22, Iss. 1-2, 1999-05 ,pp. : 81-97

Karger

Access to resources Recommend Favorite

UK Renal Registry 19th Annual Report: Chapter 12 Multisite Dialysis Access Audit in England, Northern Ireland and Wales in 2015 and 2014 PD One Year Follow-up: National and Centre-specific Analyses

By  

Nephron, Vol. 137, Iss. 1, 2017-09 ,pp. : 269-296

Karger

Access to resources Recommend Favorite